Venture Kick Stage III convertible loan · Biotech
Vale Biolabs reaches Venture Kick Stage III for brain disease research
The programme’s final stage provides a CHF 100,000 convertible loan.
Vale Biolabs has reached Stage III of Venture Kick, bringing its support across the programme to CHF 150,000. The final stage provides a CHF 100,000 convertible loan under the programme’s published terms.
The Swiss biotech combines lab-grown human brain tissue, automation and predictive AI to study disease and assess potential treatments. It measures changes in organoids over time and after drug exposure to build research datasets.
The support will help Vale develop its automated platform, expand its tissue models and train predictive systems with research and industry partners.
Use of funds
Develop automated brain organoid models and predictive datasets
Funding history
Venture Kick Stage III convertible loan · This roundCHF 100K